Oak Grove Capital’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
WA
Oak Grove Capital's JNJ Position: Q1 2022 in Review
Oak Grove Capital sold out of Johnson & Johnson (JNJ) in Q1 2022, closing a stake of 1,250 shares — an estimated $214K sold.
Oak Grove Capital first reported a position in JNJ in Q4 2017 and held it in 11 quarters. The position peaked at $748K in Q4 2017. 3,676 funds tracked by Wall St. Rank hold JNJ as of Q1 2022.
- Oak Grove Capital reported no remaining Johnson & Johnson position as of Q1 2022 after selling out during the quarter.
- Oak Grove Capital sold 1,250 Johnson & Johnson shares in Q1 2022, an estimated $214K.
- Oak Grove Capital first reported a position in Johnson & Johnson in Q4 2017 and held it in 11 quarters.
- Oak Grove Capital's Johnson & Johnson position peaked at $748K in Q4 2017.
- 3,676 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2022.
Based on Oak Grove Capital's 13F filing for Q1 2022, filed 10 May 2022.